The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity, heart disease and other chronic ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Valued at a market cap of $14.8 billion, Viatris Inc. (VTRS) is a healthcare company that operates in four segments: ...

CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.

The industry’s intellectual property manipulations are stealing from your pockets—and limiting the benefits of the Biden ...

As Gov. Gavin Newsom enters the second half of his final term, healthcare emerges as his most ambitious but glaringly ...

Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

While a stuffy nose is a common side effect of oral ED medications, switching from Cialis to shorter-lasting options like ...

Following the recent approval of its Regadenoson generic drug by the United States Food and Drug Administration (FDA), Indies ...

Patients who have a family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome Type 2 are not ...